What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas

References

• Buchsbaum MS. The frontal lobes, basal ganglia, temporal lobes as sites for schizophrenia. Schizophrenia Bulletin 1990; 16: 379–390
   PubMed Web of Science ®Google Scholar
• Pantelis C, Barnes TRE, Nelson HE. Is the concept of frontal-subcortical dementia relevant to schizophrenia. British Journal of Psychiatry 1992; 160: 442–460
   PubMed Web of Science ®Google Scholar
• Weinberger DR, Berman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. American Journal of Psychiatry 1992; 149: 890–897
   PubMed Web of Science ®Google Scholar
• Andreasen N. Brain imaging: applications in psychiatry. Washington DC: American Psychiatric Press,. 1989
   Google Scholar
• Geaney DP, Ellis PM, Shepstone BJ, Cowen PJ. Single photon emission computerized tomography: assessment of cerebral dopamine D2 receptor blockade in schizophrenia. Biological Psychiatry 1992; 32: 293–295
   PubMedGoogle Scholar
• Raichle M, Grubb R, Gado M, Eichling J, Ter-Pergossian M. Correlation between regional cerebral blood flow and oxidative metabolism. Archives of Neurology 1976; 33: 523–526
   PubMed Web of Science ®Google Scholar
• Baron G, Lebrun-Grandie P, Collard P, Crouzel C, Mestelan G, Bousser M. Non invasive measurement of blood flow, oxygen consumption and glucose utilization in the same brain regions in man by positron emission tomography. Journal of Nuclear Medicine 1982; 23: 391–399
   PubMedGoogle Scholar
• Hoyer S, Oesterreich K. Blood flow and oxidative metabolism of the brain in the course of acute schizophenia. Acta Neurologica Scandinavica Supplementum 1977; 64: 534–535
   PubMedGoogle Scholar
• Geaney D, Abou-Saleh M. The use and applications of single photon emission computerised tomography in dementia. British Journal of Psychiatry 1990; 157: S66–S75
   Google Scholar
• Lebrun-Grandie P, Baron J, Soussaline F, Loc'h C, Sastre J, Bousser M. Coupling between regional blood flow and oxygen utilization in the normal human brain: a study with positron tomography and oxygen 15. Archives of Neurology 1983; 40: 230–236
   PubMedGoogle Scholar
• Mathew RJ, Wilson WH, Tant SR. Determinants of resting regional blood flow in normal subjects. Biological Psychiatry 1986; 21: 907–914
   PubMed Web of Science ®Google Scholar
• Maes M, Dierckx R, Meltzer H, Ingels M, Schotte C, Vandewoude M, Calabrese J, Cosyns P. Regional cerebral blood flow in unipolar depression measured with Tc-99m-HMPAO single photon emission computed tomography: negative findings. Psychiatry Research: Neuroimaging 1993; 50: 77–88
   Google Scholar
• Gilman A, Goodman L, Gilman A. The pharmacological basis of therapeutics. New York: MacMillan,. 1980
   Google Scholar
• Berman K. Cortical stress tests in schizophrenia: regional cerebral blood flow studies. Biological Psychiatry 1987; 22: 1304–1326
   PubMedGoogle Scholar
• De Lisi LE, Holcomb HH, Cohen RM. Positron emission tomography in schizophrenic palients with and without neuroleptic medication. Journal of Cerebral Blood Flow and Metabolism 1985; 5: 201–206
   PubMedGoogle Scholar
• Berman KF, Doran AR, Pickar D, Weinberger DR. Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. British Journal of Psychiatry 1993; 162: 183–192
   PubMed Web of Science ®Google Scholar
• Weinberger DR, Berman KF, Illowsky BP. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Archives of General Psychiatry 1988; 45: 609–615
   PubMed Web of Science ®Google Scholar
• Joyce EM. The relevance of recent advances in functional imaging to psychiatry. Journal of Neurology, Neurosurgery and Psychiatry 1992; 55: 427–430
   PubMedGoogle Scholar
• Gur RC, Erwin RJ, Gur RE. Neurobehavioural probes for physiologic neuroimaging studies. Archives of General Psychiatry 1992; 49: 409–414
   PubMed Web of Science ®Google Scholar
• Sergent J. Brain-imaging studies of cognitive functions. Trends in Neurosciences 1994; 17: 221–227
   PubMed Web of Science ®Google Scholar
• Ingvar D, Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatrica Scandinavica 1974; 50: 425–427
   PubMed Web of Science ®Google Scholar
• Sheppard G, Gruzelier J, Manchanda R, Hirsch SR. 15O positron emission tomographic scanning in predominantly never treated acute schizophrenic patients. Lancet 1983; Dec 24/31: 1448–1452
   Google Scholar
• Volkow ND, Brodie J, Wolf AP, Angrist B, Russell J, Cancro R. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. Journal of Neurology, Neurosurgery and Psychiatry 1986; 49: 1199–1202
   PubMedGoogle Scholar
• Early TS, Reiman EM, Raichle ME, Spitznagel EL. Left globus pallidus abnormality in never medicated patients with schizophrenia. National Academy of Sciences USA 1987; 84: 561–563
   PubMed Web of Science ®Google Scholar
• Wiesel FA, Wik G, Sjogren I, Blomqvist G, Greitz T, Stone Elander S. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta Psychiatrica Scandinavica 1987; 76: 628–641
   PubMed Web of Science ®Google Scholar
• Cleghorn JM, Garnett ES, Nahmias C. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Research 1989; 28: 119–133
   PubMedGoogle Scholar
• Szechtman H, Nahmias C, Garnett S. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Archives of General Psychiatry 1988; 45: 523–532
   PubMedGoogle Scholar
• Chabrol H, Guell A, Bes A, Moron P. Cerebral blood flow in schizophrenic adolescents [letter],. American Journal of Psychiatry 1986; 143: 130
   PubMedGoogle Scholar
• Geraud M, Arne-Bes M, Guell A, Bes A. Reversibility of hemodynamic hypofrontality in schizphrenia. Journal of Cerebral Blood Flow and Metabolism 1987; 7: 9–12
   PubMedGoogle Scholar
• Clark C, Klonoff H, Tyhurst J, Li D, Martin W, Pate B. Regional cerebral glucose metabolism in three sets of identical twins with psychotic symptoms. Canadian Journal of Psychiatry 1989; 34: 263–270
   PubMedGoogle Scholar
• Hawton K, Shepstone B, Soper N, Reznek L. Single-photon emission computerised tomography (SPECT) in schizophrenia. British Journal of Psychiatry 1990; 156: 425–427
   PubMedGoogle Scholar
• Buchsbaum MS, Haier RJ, Potkin SG. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Archives of General Psychiatry 1992; 49: 935–942
   PubMed Web of Science ®Google Scholar
• Rubin P, Holm S, Friberg L. Altered modulation of prefrontal and subcortical activity in newly diagnosed schizophrenia and schizophreniform disorder: a regional cerebral blood flow study. Archives of General Psychiatry 1991; 48: 987–995
   PubMedGoogle Scholar
• Berman KF, Torrey EF, Daniel DG, Weinberger DR. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Archives of General Psychiatry 1992; 49: 927–934
   PubMedGoogle Scholar
• Andreasen NC, Rezai K, Alliger R. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Archives of General Psychiatry 1992; 49: 943–958
   PubMed Web of Science ®Google Scholar
• Siegel BV, Jr, Buchsbaum MS, Bunney WE Jr. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. American Journal of Psychiatry 1993; 150: 1325–1336
   PubMed Web of Science ®Google Scholar
• Weinberger D, Berman K, Zee R. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow (rCBF) evidence. Archives of General Psychiatry 1986; 43: 114–124
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wolf AP, Van Gelder P. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. American Journal of Psychiatry 1987; 144: 151–158
   PubMed Web of Science ®Google Scholar
• Lewis S, Ford R, Syed G, Reveley A, Toone B. A controlled study of 99mTc-HMPAO single photon emission imaging in chronic schizophrenia. Psychological Medicine 1992; 22: 27–35
   PubMed Web of Science ®Google Scholar
• Liddle PF, Friston KJ, Frith CD, Frackowiak RS. Cerebral blood flow and mental processes in schizophrenia. Journal of the Royal Society of Medicine 1992; 85: 224–227
   PubMed Web of Science ®Google Scholar
• Pardo JV, Pardo PJ, Janer KW, Raichle ME. The anterior cingulate mediates processing selection in the Stroop attentional conflict syndrome. National Academy of Sciences USA 1990; 87: 256–259
   PubMed Web of Science ®Google Scholar
• Buchsbaum MS, Nuechterlein KH, Haier RJ. Glucose metabolic rate in normals and schizophrenics during the continuous performance test assessed by positron emission tomography. British Journal of Psychiatry 1990; 156: 216–227
   PubMed Web of Science ®Google Scholar
• Martinot J, Hardy P, Feline A. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. American Journal of Psychiatry 1990; 147: 1313–1317
   PubMed Web of Science ®Google Scholar
• Baxter L, Phelps M, Mazziotta J. Cerebral metabolic rates for glucose in mood disorders. Archives of General Psychiatry 1985; 42: 441–447
   PubMed Web of Science ®Google Scholar
• Ebert D, Feistel H, Barocka A. Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: a study with Tc-HM-PAO. Psychiatry Research: Neuroimaging 1991; 40: 247–251
   PubMed Web of Science ®Google Scholar
• Mayberg H, Jeffery P, Wagner H, Simpson S. Regional cerebral blood flow in patients with depression measured with Tc-99m HMPAO SPECT (abstract). Journal of Nuclear Medicine 1991; 32: 951
   Google Scholar
• Kling AC, Metter EJ, Riege WH, Kuhl DE. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. American Journal of Psychiatry 1986; 143: 175–180
   PubMed Web of Science ®Google Scholar
• Buchsbaum M, De Lisi L, Holcomb H. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Archives of General Psychiatry 1984; 41: 1159–1166
   PubMed Web of Science ®Google Scholar
• Musalek M, Podreka I, Suess E. Neurophysiological aspects of auditory hallucinations: 99mTc-(HMPAO)-SPECT investigations in patients with auditory hallucinations and normal controls - a preliminary report. Psychopathology 1988; 21: 275–280
   PubMedGoogle Scholar
• Wolkin A, Jaeger J, Brodie J. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. American Journal of Psychiatry 1985; 142: 564–571
   PubMed Web of Science ®Google Scholar
• DeLisi LE, Holcomb HH, Cohen RM. Positron emission tomography in schizophrenic patients with and without neuroleptic medication. Journal of Cerebral Blood Flow and Metabolism 1985; 5: 201–206
   PubMed Web of Science ®Google Scholar
• Rubin P, Holm S, Madsen PL. Regional cerebral blood flow distribution in newly diagnosed schizophrenia and schizophreniform disorder. Psychiatry Research 1994; 53: 57–75
   PubMedGoogle Scholar
• Slater E, Beard AW, Glithero E. The schizophrenia like psychoses of epilepsy. British Journal of Psychiatry 1963; 109: 95–150
   PubMed Web of Science ®Google Scholar
• Roberts GW. Schizophrenia: a neuropathological perspective. British Journal of Psychiatry 1991; 158: 8–17
   PubMedGoogle Scholar
• Friston KJ, Liddle PF, Frith CD, Hirsch SR, Frackowiak RSJ. The medial temporal region in schizophrenia. A PET study. Brain 1992; 115: 367–382
   Google Scholar
• De Lisi LE, Buchsbaum MS, Holcomb HH. Increased temporal lobe glucose use in chronic schizophrenia. Biological Psychiatry 1989; 25: 835–851
   PubMedGoogle Scholar
• Mathew R, Wilson W, Tant S, Robinson L, Prakash R. Abnormal resting regional blood flow patterns and their correlates in schizophrenia. Archives of General Psychiatry 1988; 45: 542–549
   PubMed Web of Science ®Google Scholar
• Matsuda H, Gyobu T, Hisada K. Iodine-123 iodoamphetamine brain scan in a patient with auditory hallucinations. Journal of Nuclear Medicine 1988; 29: 558–560
   PubMed Web of Science ®Google Scholar
• Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RSJ. Patterns of cerebral blood flow in schizophrenia. British Journal of Psychiatry 1992; 160: 179–186
   PubMed Web of Science ®Google Scholar
• Notordonato H, Gonzalez-Avilez A, Van Heertum R, O'Connell RA, Yudd AP. The potential value of serial cerebral SPECT scanning in the evaluation of psychiatric illness. Clinical Nuclear Medicine 1989; 14: 319–322
   PubMedGoogle Scholar
• Ebert D, Feistel H, Kaschka W. Left temporal hypoperfusion in catatonic syndromes. Psychiatry Research: Neuroimaging 1992; 45: 239–241
   Google Scholar
• Gordon E, Barry RJ, Anderson J. Single photon emission computed tomography (SPECT) measures of brain function in schizophrenia. Australian and New Zealand Journal of Psychiatry 1994; 28: 446–152
   PubMed Web of Science ®Google Scholar
• Tamminga C, Thaker G, Buchanan R, Kirkpatrick B, Alphs L, Chase T, Carpenter W. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry 1992; 49: 522–530
   PubMed Web of Science ®Google Scholar
• Busatto GF, Costa DC, Ell PJ, Pilowsky LS, David AD, Kerwin RW. Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: a 99mTc-HMPAO single photon emission tomography (SPET) study. Psychological Medicine 1994; 24: 463–472
   PubMedGoogle Scholar
• Park S, Holzman PS. Schizophrenics show spatial working memory deficits. Archives of General Psychiatry 1992; 49: 975–982
   PubMed Web of Science ®Google Scholar
• Goldman-Rakic PS, Friedman HR. The circuitry of working memory revealed by anatomy and metabolic imaging. Frontal lobe function and dysfunction. Oxford: Oxford University Press, HS Levin, HM Eisenberg, AL Benton, 1991; 72–91
   Google Scholar
• Sawaguchi T, Goldman-Rakic PS. The role of Dl-dopamine receptor in working memory: local injections of dopamine anatagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed response task. Journal of Neurophysiology 1994; 71: 515–528
   PubMed Web of Science ®Google Scholar
• Erbas B, Kumbasar H, Erbengi G, Bekdik C. Tc-HMPAO/SPECT determination of regional cerebral blood flow changes in schizophrenics. Clinical Nuclear Medicine 1990; 15: 904–907
   PubMed Web of Science ®Google Scholar
• Musalek M, Podreka I, Walter H. Regional brain function in hallucinations: a study of regional cerebral blood How with 99m-Tc-HMPAO-SPECT in patients with auditory hallucinations, tactile hallucinations and normal controls. Comprehensive Psychiatry 1989; 30: 99–108
   PubMedGoogle Scholar
• Andreasen N, Rezai K, Alliger R. Hypofrontality in neuroleptic naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single photon emission computed tomography and the Tower of London. Archives of General Psychiatry 1992; 49: 943–958
   PubMed Web of Science ®Google Scholar
• Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Archives of General Psychiatry 1992; 49: 959–965
   PubMed Web of Science ®Google Scholar
• Farde L, Nordstrom AL. PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. British Journal of Psychiatry Supplement 1992; 17: 30–33
   Google Scholar
• Wong DF, Wagner HN, Jr, Tune LE. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986; 234: 1558–1563, Erratum: Science 1987; 235:623
   PubMed Web of Science ®Google Scholar
• Farde L, Halldin C, Stone-Elander S, Sedvall G. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride. Psychopharmacology (Berlin) 1987; 92: 278–284
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Carson R, Diksic M. Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. Schizophrenia Bulletin 1988; 14: 471–484
   PubMedGoogle Scholar
• Tune LE, Wong D, Pearlson G. Elevated dopamine 2 receptor density in 23 schizophrenic patients: a positron emission tomography study with 11C N-methylspiperone. Schizophrenia Research 1992; 22: 147
   Google Scholar
• Tune LE, Wong DF, Pearlson G. Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone. Psychiatry Research 1993; 49: 219–237
   PubMed Web of Science ®Google Scholar
• Farde L, Pauli S, Stone-Elander S. D2 dopamine receptors in neuroleptic naive schizophrenic patients. Archives of General Psychiatry 1990; 47: 213–219
   PubMed Web of Science ®Google Scholar
• Martinot JL, Peron-Magnan P, Huret JD. Striatal D2 dopaminergic receptors assessed by positron emission tomography and 76Br-bromospiperone in untreated schizophrenics. American Journal of Psychiatry 1990; 147: 44–50
   PubMedGoogle Scholar
• Martinto JL, Paillere-Martinot ML, Loc'h C. The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromosiluride. British Journal of Psychiatry 1991; 158: 346–350
   PubMedGoogle Scholar
• Hietala J, Syvalahti E, Vuorio K. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Archives of General Psychiatry 1994; 51: 116–123
   PubMed Web of Science ®Google Scholar
• Pilowsky LS, Costa DC, Ell PJ, Verhoeff LG, Murray RM, Kerwin RW. D2 dopamine receptor binding in the basal ganglia of antipsychotic free schizophrenic patients. An l23I-IBZM single photon emission computerised tomography study. British Journal of Psychiatry 1994; 164: 16–26
   PubMedGoogle Scholar
• Pycock CJ, Kerwin RJ, Carter CJ. Effect of lesion of cortical dopamine terminals on subcortical receptors in rats. Nature 1980; 286: 74–77
   PubMed Web of Science ®Google Scholar
• Christie MJ, Rowe PJ, Bernt PM. Effect of excitotoxin lesions in the medical prefrontal cortex on cortical and subcortical catecholamine turnover in the rat. Journal of Neurochemistry 1986; 47: 1593–1597
   PubMedGoogle Scholar
• Grace AA. Phasic versus tonic dopomine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991; 41: 1–24
   PubMed Web of Science ®Google Scholar
• Seeman P. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 1992; 7: 261–264
   Google Scholar
• Seeman P, Guan H, Van Tol HHM. Dopamine D4 receptors elevated in schizophrenia. Nature 1993; 365: 441–445
   PubMed Web of Science ®Google Scholar
• Van Tol HH, Bunzow JR, Guan HC. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350: 610–614
   PubMed Web of Science ®Google Scholar
• Lewine RR, Gulley LR, Risch SC, Jewart R, Houpt JL. Sexual dimorphism, brain morphology and schizophrenia. Schizophrenia Bulletin 1990; 16: 195–203
   PubMed Web of Science ®Google Scholar
• Flor-Henry P. Influence of gender in schizophrenia as related to other psychopathological syndromes. Schizophrenia Bulletin 1990; 16: 211–227
   PubMed Web of Science ®Google Scholar
• Castle DJ, Murray RM. The neurodevelopmental basis of sex differences in schizophrenia. Psychological Medicine 1991; 21: 565–575
   PubMed Web of Science ®Google Scholar
• Farde L, Wiesel FA, Halldin C, Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Archives of General Psychiatry 1988; 45: 71–76
   PubMed Web of Science ®Google Scholar
• Baron JC, Marinot JL, Cambon H. Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology 1989; 99: 463–472
   PubMedGoogle Scholar
• Smith M, Wolf AP, Brodie JD. Serial [18F]N-methyl-spiroperidol PET studies to measure changes in antipsychotic drug D2 receptor occupancy in schizophrenic patients. Biological Psychiatry 1988; 23: 653–663
   PubMedGoogle Scholar
• Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NPL, Kerwin RW. Clozapine, single photon emission tomography and the D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet 1992; 340: 199–202
   PubMed Web of Science ®Google Scholar
• Kane J, Honigfeld G, Singer J, Meltzer H. Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry 1988; 45: 789–796
   PubMed Web of Science ®Google Scholar
• Coppens HJ, Slooff CJ, Paans AMJ, Wiegman T, Vaalburg W, Korf J. High central D2 dopamine receptor occupancy as assessed with positron emission tomography in medicated but treatment resistant schizophrenic patients. Biological Psychiatry 1991; 29: 629–634
   PubMedGoogle Scholar
• Wolkin A, Barouche F, Wolf AP. Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. American Journal of Psychiatry 1989; 146: 905–908
   PubMed Web of Science ®Google Scholar
• Volk S, Maul FD, Hor G. Dopamine D2 receptor occupancy measured by single photon emission computed tomogaphy with l23I-iodobenzamide in chronic schizophrenia. Psychiatry Research: Neuroimaging 1994; 55: 111–118
   Google Scholar
• Dean B, Copolov DL. Dopamine receptors. Australian Journal of Psychopharmacology 1994; 7: 10–15
   Google Scholar
• Waddington JL, O'Callaghan E, Larkin C, Redmond O, Stack J, Ennis JT. Magnetic resonance imaging and spectroscopy in schizophrenia. British Journal of Psychiatry Supplement. 1990; 56–65
   Google Scholar
• Guze BH. Magnetic resonance spectoscopy. A technique for functional imaging. Archives of General Psychiatry 1991; 48: 572–574
   PubMed Web of Science ®Google Scholar
• Kershavan MS, Pettegrew JW, Panchalingam K, Kaplan D, Brar J, Campbell K. In vivo 31-P magnetic resonance (NMR) spectroscopy of the frontal lobe metabolism in neuroleptic naive first episode psychoses: preliminary studies. Schizophrenia Research 1989; 2: 122
   Google Scholar
• Pettegrew JW, Keshavan MS, Panchalingam K. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy [see comments]. Archives of General Psychiatry 1991; 48: 563–568
   PubMed Web of Science ®Google Scholar
• Williamson P, Drost D, Stanley J, Carr T, Morrison S, Merskey H. Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls [letter; comment]. Archives of General Psychiatry 1991; 48: 578
   PubMed Web of Science ®Google Scholar
• O'Callaghan E, Larkin C, Redmond O. 31P magnetic resonance spectroscopy of the left temporal lobe in schizophrenia: procedures and preliminary results. Schizophrenia Research 1989; 2: 125
   Google Scholar
• Calabrese G, Deicken RF, Fein G, Metrin EL, Schoenfeld F, Weiner MW. 31 Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biological Psychiatry 1992; 32: 26–32
   PubMed Web of Science ®Google Scholar
• Williamson PC. Schizophrenia as a brain disease. Archives of Neurology 1993; 50: 1096–1097
   PubMedGoogle Scholar
• Stanley JA, Williamson PC, Drost DJ, Carr I, Rylett J, Merskey H. In vivo proton MRS in never treated schizophrenics. Proceedings of the American Psychiatric Association. 1992
   Google Scholar
• David A, Blamire A, Breiter H. Functional magnetic resonance imaging. A new technique with implications for psychology and psychiatry. British Journal of Psychiatry 1994; 164: 2–7
   Google Scholar
• Cohen MS, Bookheimer SY. Localization of brain function using magnetic resonance imaging. Trends in Neurosciences 1994; 17: 268–277
   PubMed Web of Science ®Google Scholar